Busting Biotech's Bottlenecks: Veronica Breckenridge on the Path to Industrial Scale
Karl and Erum sit down with Veronica Breckenridge, founder of First Bight Ventures, to discuss how the convergence of biology and technology is driving the biggest innovations of the 21st century. Drawing from her deep tech background, including her time at Apple, Veronica explores rapid advancements in genome sequencing, AI-driven biotech, and the vast untapped potential of microbes, emphasizing why now is the time to harness biology to tackle global challenges in health, nutrition, sustainability, and manufacturing. From synthetic biology startups to biomanufacturing at scale, this episode delves into the future of biomaterials and how venture capital can accelerate the next wave of biotech breakthroughs—making it a must-listen for anyone interested in scaling biotech innovations, investing in the bioeconomy, or exploring the intersection of computation and biology.
Chapters:
00:00:00 - How Biology is Moving Faster Than Moore’s Law
00:00:17 - Checking In from Panama
00:00:42 - Exploring Panama City’s Biotech Potential
00:01:26 - A Futuristic Robot Massage Experience
00:02:11 - Reflecting on International Women's Day
00:02:40 - Networking with Women in Biotech in Brooklyn
00:05:27 - Inside the Merck Digital Sciences Studio Event
00:06:19 - Breakthroughs Shaping the Future of Drug Development
00:07:15 - The Biggest Hurdles for Startups in Pharma
00:16:20 - A Deep Dive with Veronica Breckenridge
00:30:41 - Why Manufacturability Matters in Biotech
00:31:28 - The Role of Research and Pilot Facilities
00:33:48 - How Scientific Founders Can Accelerate Their Business
00:35:25 - Houston’s Rising Status in Biomanufacturing
00:39:12 - The Power of Collaboration and Mentorship
00:43:04 - What It Takes to Scale and Commercialize Biotech Innovations
00:48:12 - First Bight Ventures’ Approach to Investing in the Bioeconomy
00:51:26 - Building the Biotech Ecosystem & What’s Coming Next
00:54:28 - Final Advice for Startups Looking to Scale
